NCT07020091

Brief Summary

This retrospective observational cohort study aims to identify early predictors of short- and mid-term mortality in adult patients who achieved return of spontaneous circulation (ROSC) after cardiac arrest. Eligible patients admitted to the intensive care unit between January 1, 2024 and May 31, 2025 were identified retrospectively from electronic medical records following institutional ethics approval. Clinical, biochemical, and resuscitation-related parameters recorded within the first 24 hours of ICU admission were analyzed. The primary objective was to determine factors independently associated with short-term mortality. Six-month mortality was additionally assessed using hospital records and the national death registry. The findings are expected to improve risk stratification and clinical decision-making in post-cardiac arrest care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
168

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2024

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

June 5, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 13, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
4 months until next milestone

Results Posted

Study results publicly available

May 8, 2026

Completed
Last Updated

May 8, 2026

Status Verified

April 1, 2026

Enrollment Period

1.7 years

First QC Date

June 5, 2025

Results QC Date

March 27, 2026

Last Update Submit

April 16, 2026

Conditions

Keywords

Cardiac ArrestROSCIn-Hospital MortalityICUPost-Resuscitation CareNeurological Outcome

Outcome Measures

Primary Outcomes (1)

  • 30-Day Mortality

    All-cause mortality within 30 days of ICU admission following ROSC.

    30 days after ICU admission

Secondary Outcomes (2)

  • In-Hospital Mortality

    From ICU admission to hospital discharge (up to 60 days)

  • 6-Month Mortality

    6 months after ICU admission

Study Arms (1)

ROSC Cohort

Adult patients (≥18 years old) who achieved return of spontaneous circulation (ROSC) after cardiac arrest and were admitted to the intensive care unit. These patients are prospectively followed to evaluate clinical and biochemical predictors of in-hospital mortality.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients (≥18 years old) who achieved return of spontaneous circulation (ROSC) after cardiac arrest and were admitted to the intensive care unit (ICU) at Gazi Yaşargil Training and Research Hospital, Turkey. Patients are consecutively enrolled and observed for outcomes related to in-hospital and 6-month mortality.

You may qualify if:

  • Age ≥ 18 years
  • Achieved return of spontaneous circulation (ROSC) after cardiac arrest
  • Admitted to the intensive care unit (ICU)
  • Informed consent obtained from patient or legal representative (if applicable)

You may not qualify if:

  • Age \< 18 years
  • Known pregnancy
  • Brain death at the time of ICU admission
  • Patients with missing key clinical or laboratory data
  • Declined participation or legal refusal

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gazi Yaşargil Training and Research Hospital

Diyarbakır, Kayapinar, 21070, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Critical IllnessHeart ArrestHypoxia-Ischemia, BrainComa

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsHeart DiseasesCardiovascular DiseasesBrain IschemiaCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesHypoxia, BrainVascular DiseasesHypoxiaSigns and Symptoms, RespiratorySigns and SymptomsUnconsciousnessConsciousness DisordersNeurobehavioral ManifestationsNeurologic Manifestations

Limitations and Caveats

This study is limited by its retrospective single-center design. Adverse events were not systematically collected. Residual confounding cannot be excluded.

Results Point of Contact

Title
Ahmet Duzgun, MD, Intensive Care Specialist
Organization
Department of Intensive Care, University of Health Sciences, Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkey

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Specialist in Internal Medicine and Intensive Care

Study Record Dates

First Submitted

June 5, 2025

First Posted

June 13, 2025

Study Start

May 1, 2024

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

May 8, 2026

Results First Posted

May 8, 2026

Record last verified: 2026-04

Locations